MRNA Moderna Inc
Moderna Inc price
-12.41% Past Week
Market Cap
38.06B
Dayโs Range
52W Range
Volume (3M)
3.83M
Price-Earnings Ratio
36.74
Revenue
10.55B
Moderna Inc Latest News



About Moderna Inc
Moderna Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, with a focus on the development of RNA therapeutics, and primarily on mRNA vaccines. The companyโs mission is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. One of the industryโs leading mRNA technology platforms, the firm has been in operation since 2010 and operates globally.
Engaged in drug discovery and development, Moderna has a robust and rapidly expanding pipeline, with products aimed at viruses such as HIV, RSV, the Zika virus, and the Epstein Barr virus. The firmโs focus remains on the development of mRNA vaccines, which use a copy of a molecule called messenger RNA to produce an immune response in the human body. The firm is known for bringing to market the Moderna COVID-19 vaccine.
The company is developing vaccines and therapeutics for various infectious diseases, immuno-oncology, rare diseases, autoimmune diseases, and cardiovascular diseases, working both independently and with its strategic partners within the biotechnology industry. The firm is listed on the NASDAQ, where it trades under the ticker MRNA.
Follow Moderna Inc and stay up to date on MRNA value changes here on eToro.
Show MoreStรฉphane Bancel, MBA
CEO
3.9K
Employees
2010
Founded
Cambridge, Massachusetts, US
HQ
Upcoming Events
2
NOV
REPORTS
Moderna Inc Q3 2023 earnings report is expected to be released before market open
Consensus
Moderate Buy
Price Target
164.48
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
37
Very Low
Industry
Avg. 45
38
Environment
39
Social
35
Governance
People Also Bought
- PFE Pfizer -0.49%
- GILD Gilead Sciences Inc -0.35%
- AZN.L AstraZeneca 1.32%
- NVAX Novavax Inc 4.70%
- BNTX BioNTech SE-ADR -1.68%